Tar Heel Times
Your comprehensive source for Tar Heel sports news

UNC ranked 7th among biomedical research institutions


Researchers at the University of North Carolina at Chapel Hill are using genetically engineered mouse models to help predict how humans will respond to different chemotherapy drug combinations used to fight breast cancer. Last year, UNC scientists identified biomarkers for challenging molecular subtypes of human breast cancer in genetically engineered mice, specifically looking for types that have few known targets and available therapies. (Fierce Biotech Research)


Share: Facebook | Twitter | Email

Related:

Recent Campus Connections News:

Marine Corps veteran realizing her dream at UNC

Disabled UNC Business School Grad Leaves Mark

The Georgia And North Carolina Rivalry Extends Beyond The Football Field

UNC Ranks 35th Among Universities in U.S. Invention Patents

A long legacy of research at UNC


© 2005-2016 Tar Heel Times | Contact | Privacy Policy | Site Map | RSS | Did UNC Win?

Tar Heel Times is an unofficial resource for UNC fans and is not affiliated with the University of North Carolina.